Details of a Researcher - Shimada, Hiroko

Shimada, Hiroko

写真a

Affiliation: Keio Frontier Research & Education Collaborative Square (K-FRECS), K-FRECS at Tonomachi (Mita)

Position: Project Senior Assistant Professor (Non-tenured)/Project Assistant Professor (Non-tenured)/Project Lecturer (Non-tenured)

Page Top ▲

Career 【 Display / hide 】

2013.07

-

2016.12

National Eye Institute (NEI) / NIH

Page Top ▲

Research Keywords 【 Display / hide 】

Stem cell, Neural differentiation

Page Top ▲

Papers 【 Display / hide 】

Reserpine maintains photoreceptor survival in retinal ciliopathy by resolving proteostasis imbalance and ciliogenesis defects

Chen H.Y., Swaroop M., Papal S., Mondal A.K., Song H.B., Campello L., Tawa G.J., Regent F., Shimada H., Nagashima K., de Val N., Jacobson S.G., Zheng W., Swaroop A.

eLife (eLife) 12 2023.03

　View Summary

Ciliopathies manifest from sensory abnormalities to syndromic disorders with multi-organ pathologies, with retinal degeneration a highly penetrant phenotype. Photoreceptor cell death is a major cause of incurable blindness in retinal ciliopathies. To identify drug candidates to maintain photoreceptor survival, we performed an unbiased, high-throughput screening of over 6,000 bioactive small molecules using retinal organoids differentiated from induced pluripotent stem cells (iPSC) of rd16 mouse, which is a model of Leber congenital amaurosis (LCA) type 10 caused by mutations in the cilia-centrosomal gene CEP290. We identified five non-toxic positive hits, including the lead molecule reserpine, which maintained photoreceptor development and survival in rd16 organoids. Reserpine also improved photoreceptors in retinal organoids derived from induced pluripotent stem cells of LCA10 patients and in rd16 mouse retina in vivo. Reserpine-treated patient organoids revealed modulation of signaling pathways related to cell survival/death, metabolism, and proteostasis. Further investigation uncovered dysregulation of autophagy associated with compromised primary cilium biogenesis in patient organoids and rd16 mouse retina. Reserpine partially restored the balance between autophagy and the ubiquitin-proteasome system at least in part by increasing the cargo adaptor p62, resulting in improved primary cilium assembly. Our study identifies effective drug candidates in preclinical studies of CEP290 retinal ciliopathies through cross-species drug discovery using iPSC-derived organoids, highlights the impact of proteostasis in the pathogenesis of ciliopathies, and provides new insights for treatments of retinal neurodegeneration.
- Access to Document (DOI)
Human PSCs determine the competency of cerebral organoid differentiation via FGF signaling and epigenetic mechanisms

Ideno H., Imaizumi K., Shimada H., Sanosaka T., Nemoto A., Kohyama J., Okano H.

iScience (iScience) 25 ( 10 ) 2022.10

　View Summary

Various culture methods have been developed for maintaining human pluripotent stem cells (PSCs). These PSC maintenance methods exhibit biased differentiation; for example, feeder-dependent PSCs efficiently yield cerebral organoids, but it is difficult to generate organoids from feeder-free PSCs. It remains unknown how PSC maintenance conditions affect differentiation. In this study, we identified fibroblast growth factor (FGF) signaling in feeder-free PSC maintenance as a key factor that determines the differentiation toward cerebral organoids. The inhibition of FGF signaling in feeder-free PSCs rescued organoid generation to the same level in feeder-dependent cultures. FGF inhibition induced DNA methylation at the WNT5A locus, and this epigenetic change suppressed the future activation of non-canonical Wnt signaling after differentiation, leading to reliable cerebral organoid generation. This study underscores the importance of PSC culture conditions for directed differentiation into cerebral organoids, and the epigenetic status regulated by FGF signaling is involved in the underlying mechanisms.
- Access to Document (DOI)
In vitro modeling and rescue of ciliopathy associated with IQCB1/NPHP5 mutations using patient-derived cells

Kruczek K., Qu Z., Welby E., Shimada H., Hiriyanna S., English M.A., Zein W.M., Brooks B.P., Swaroop A.

Stem Cell Reports (Stem Cell Reports) 17 ( 10 ) 2172 - 2186 2022.10

ISSN 22136711

　View Summary

Mutations in the IQ calmodulin-binding motif containing B1 (IQCB1)/NPHP5 gene encoding the ciliary protein nephrocystin 5 cause early-onset blinding disease Leber congenital amaurosis (LCA), together with kidney dysfunction in Senior-Løken syndrome. For in vitro disease modeling, we obtained dermal fibroblasts from patients with NPHP5-LCA that were reprogrammed into induced pluripotent stem cells (iPSCs) and differentiated into retinal pigment epithelium (RPE) and retinal organoids. Patient fibroblasts and RPE demonstrated aberrantly elongated ciliary axonemes. Organoids revealed impaired development of outer segment structures, which are modified primary cilia, and mislocalization of visual pigments to photoreceptor cell soma. All patient-derived cells showed reduced levels of CEP290 protein, a critical cilia transition zone component interacting with NPHP5, providing a plausible mechanism for aberrant ciliary gating and cargo transport. Disease phenotype in NPHP5-LCA retinal organoids could be rescued by adeno-associated virus (AAV)-mediated IQCB1/NPHP5 gene augmentation therapy. Our studies thus establish a human disease model and a path for treatment of NPHP5-LCA.
- Access to Document (DOI)
A next-generation iPSC-derived forebrain organoid model of tauopathy with tau fibrils by AAV-mediated gene transfer

Shimada H., Sato Y., Sasaki T., Shimozawa A., Imaizumi K., Shindo T., Miyao S., Kiyama K., Kondo T., Shibata S., Ishii S., Kuromitsu J., Aoyagi H., Ito D., Okano H.

Cell Reports Methods (Cell Reports Methods) 2 ( 9 ) 2022.09

　View Summary

It is known that the human cellular models of Alzheimer's disease (AD) and tauopathy can only recapitulate the very early stage of the disease. To overcome these limitations, we developed a technology to make forebrain organoids (FBOs) from feeder-free induced pluripotent stem cells (iPSC)s by regulating a FGF2 concentration and applied this method to generate FBOs from patients with familial AD (fAD FBOs). The obtained fAD FBOs recapitulated the amyloid-β pathology and increased tau phosphorylation but not tau aggregates. To fully induce the tau pathology, FBOs were injected with adeno-associated virus (AAV)-expressing P301L mutant tau. In these Tau-P301L FBOs, tau fibrils were observed in the neuronal cell body and neurites with immunoelectron microscopy, in addition to the sarkosyl-insoluble and thioflavin S-positive phospho-tau aggregates. Collectively, this model can be used as a platform for investigating pathogenetic mechanisms and evaluation of target molecules for drug discovery for tauopathy.
- Access to Document (DOI)
In Vitro Modeling Using Ciliopathy-Patient-Derived Cells Reveals Distinct Cilia Dysfunctions Caused by CEP290 Mutations

Shimada, Hiroko, Lu, Quanlong, Insinna-Kettenhofen, Christine, Nagashima, Kunio, English, Milton A., Semler, Elizabeth M., Mahgerefteh, Jacklyn, Cideciyan, Artur V., Li, Tiansen, Brooks, Brian P., Gunay-Aygun, Meral, Jacobson, Samuel G., Cogliati, Tiziana, Westlake, Christopher J., Swaroop, Anand

CELL REPORTS 20 ( 2 ) 384 - 396 2017.07

Research paper (scientific journal), ISSN 2211-1247
- Access to Document (DOI)

display all >>

Page Top ▲

Papers, etc., Registered in KOARA 【 Display / hide 】

Efficient derivation of neural stem/progenitor cells from common marmoset embryonic stem cells for preclinical study of spinal cord injury

Shimada, Horoko

科学研究費補助金研究成果報告書 2011

Page Top ▲

Presentations 【 Display / hide 】

Development of induced pluripotent stem cells (iPSCs)-based therapies for blinding retinal neurodegenerative diseases.

SHIMADA Hiroko

2014 Focus on Fellows, NEI/NIH,

2014.10
,
Poster presentation
Development of induced pluripotent stem cells (iPSCs)-based therapies for blinding retinal neurodegenerative diseases.

SHIMADA Hiroko

NIH-Japan-JSPS Symposium,

2014.10
,
Poster presentation
Efficient derivation of neural stem cells from common marmoset ES　cells and iPS cells

SHIMADA Hiroko

ISSCR 10th Annual Meeting,

2012.06
,
Poster presentation
Efficient derivation of neural stem cells from common marmoset ES　cells and iPS cells.

SHIMADA Hiroko

Frontiers in Biomedical Researches on Marmosets as a Primate Model Japan Society for Marmoset Research,

2012.02
,
Poster presentation
Efficient derivation of neural stem cells from common marmoset ES cells and iPS cells

SHIMADA Hiroko

Neuroscience 2011, SfN's 41st annual meeting,

2011.11
,
Poster presentation